Mariam Berberian, NP
Nurse Practitioner · Burbank
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
- Since medical school
- 6 years
- Graduated 2020
Offices
2 locations · Foveo Healthcare A Professional Medical Corporation · All for Health Health for All Inc
Looking this up.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Mariam Berberian’s office to ask if they take your plan before you enroll.
Medicaid work
$25,364 in 2024
Medicaid paid $25,364 for 280 billed services this clinician did in 2024, up to 35 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 149 | $25,364 |
| Psychiatric diagnostic evaluation with medical services | 47 | $0 |
| Short return visit (20+ min) | 84 | $0 |
| 2024 | 280 | 3 | 35 | $25,364 |
| 2022 | 748 | 3 | 191 | $38,989 |
| 2021 | 5,568 | 4 | 184 | $295,454 |
| 2020 | 4,078 | 5 | 165 | $219,595 |
See the largest Medicaid services in earlier years
2022
| Clinic visit/encounter, all-inclusive | 259 | $31,188 |
| Short return visit (20+ min) | 451 | $7,180 |
| Return visit (30+ min) | 38 | $621 |
2021
| Clinic visit/encounter, all-inclusive | 1,933 | $230,218 |
| Short return visit (20+ min) | 3,264 | $51,741 |
| Psychiatric diagnostic evaluation with medical services | 179 | $9,001 |
| Return visit (30+ min) | 192 | $4,494 |
2020
| Clinic visit/encounter, all-inclusive | 1,425 | $167,974 |
| Short return visit (20+ min) | 1,891 | $27,257 |
| Psychiatric diagnostic evaluation with medical services | 358 | $17,329 |
| Return visit (30+ min) | 392 | $7,035 |
| Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only | 12 | $0 |
Drugs they prescribed that Part D paid
$25,449
Pharmacies billed $25,449 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 814) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.
807 generic and fewer than 11 brand-name prescriptions · $25,449 in drug cost · 106 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Aripiprazole | 41 | $3,996 | $97 |
| Mirtazapine | 95 | $1,614 | $17 |
| Olanzapine | 31 | $979 | $32 |
| Bupropion Xl | 44 | $704 | $16 |
| Duloxetine | 41 | $680 | $17 |
See all 23 drugs
| Aripiprazole | 41 | $3,996 | $97 |
| Mirtazapine | 95 | $1,614 | $17 |
| Olanzapine | 31 | $979 | $32 |
| Bupropion Xl | 44 | $704 | $16 |
| Duloxetine | 41 | $680 | $17 |
| Quetiapine | 43 | $670 | $16 |
| Lurasidone | 14 | $568 | $41 |
| Gabapentin | 37 | $377 | $10 |
| Lamotrigine | 20 | $366 | $18 |
| Escitalopram | 40 | $355 | $9 |
| Venlafaxine Hcl Er | 24 | $337 | $14 |
| Sertraline | 88 | $173 | $2 |
| Hydroxyzine | 11 | $173 | $16 |
| Trazodone | 49 | $129 | $3 |
| Lithium Carbonate | 14 | $99 | $7 |
| Buspirone | 21 | $98 | $5 |
| Fluoxetine | 31 | $88 | $3 |
| Risperidone | 15 | $64 | $4 |
| Clonazepam | 34 | $55 | $2 |
| Zolpidem | 14 | $36 | $3 |
| Alprazolam | 13 | $32 | $2 |
| Diazepam | 14 | $26 | $2 |
| Lorazepam | 15 | $11 | $1 |
Year by year
| 2024 | 814 | 81 | 0% (0) | None | $25,449 |
| 2023 | 189 | 37 | 0% (0) | None | $4,976 |
| 2022 | 289 | 42 | 0% (0) | 5% | $30,753 |
| 2021 | 758 | 50 | 0% (0) | 3% | $51,515 |
| 2020 | 489 | 45 | 0% (0) | None | $23,791 |
| 2017 | 83 | 30 | None | 17% | $2,659 |
| 2016 | 160 | 44 | 16% (26) | 26% | $8,091 |
| 2015 | 54 | 14 | None | 41% | $3,740 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 7 drugs
| Aripiprazole | 20 | $1,028 | $51 |
| Bupropion Xl | 29 | $332 | $11 |
| Escitalopram | 23 | $290 | $13 |
| Quetiapine | 12 | $258 | $21 |
| Mirtazapine | 13 | $247 | $19 |
| Sertraline | 22 | $188 | $9 |
| Gabapentin | 19 | $127 | $7 |
2022: 10 drugs
| Duloxetine | 20 | $1,245 | $62 |
| Aripiprazole | 14 | $1,192 | $85 |
| Escitalopram | 43 | $506 | $12 |
| Mirtazapine | 31 | $422 | $14 |
| Gabapentin | 20 | $206 | $10 |
| Sertraline | 21 | $200 | $10 |
| Trazodone | 21 | $181 | $9 |
| Buspirone | 14 | $128 | $9 |
| Paroxetine | 11 | $97 | $9 |
| Quetiapine | 18 | $77 | $4 |
2021: 16 drugs
| Invega Sustenna | 13 | $24,692 | $1,899 |
| Duloxetine | 58 | $2,310 | $40 |
| Aripiprazole | 46 | $1,820 | $40 |
| Prazosin | 14 | $1,056 | $75 |
| Trazodone | 86 | $729 | $8 |
| Escitalopram | 88 | $723 | $8 |
| Mirtazapine | 59 | $649 | $11 |
| Sertraline | 63 | $489 | $8 |
| Buspirone | 44 | $474 | $11 |
| Propranolol | 21 | $258 | $12 |
| Paroxetine | 26 | $245 | $9 |
| Quetiapine | 46 | $225 | $5 |
| Gabapentin | 47 | $200 | $4 |
| Bupropion Hcl Sr | 22 | $156 | $7 |
| Lorazepam | 17 | $80 | $5 |
| Citalopram Hbr | 16 | $38 | $2 |
2020: 12 drugs
| Aripiprazole | 30 | $2,652 | $88 |
| Quetiapine | 37 | $633 | $17 |
| Buspirone | 30 | $544 | $18 |
| Duloxetine | 28 | $459 | $16 |
| Trazodone | 64 | $409 | $6 |
| Sertraline | 43 | $396 | $9 |
| Escitalopram | 57 | $322 | $6 |
| Mirtazapine | 19 | $229 | $12 |
| Propranolol | 18 | $212 | $12 |
| Paroxetine | 22 | $199 | $9 |
| Bupropion Hcl Sr | 13 | $91 | $7 |
| Citalopram Hbr | 25 | $76 | $3 |
2016: 2 drugs
| Furosemide | 14 | $75 | $5 |
| Levofloxacin | 11 | $62 | $6 |
Money from drug and device companies
$1,606 in 2025
| 2025 | 8 | 27 | None | $1,606 |
| 2024 | 7 | 23 | None | $1,262 |
| 2023 | 6 | 13 | None | $706 |
| 2022 | 2 | 3 | None | $248 |
| 2021 | 1 | 1 | None | $47 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Teva Pharmaceuticals USA | Austedo Xr | $441 | 6 payments
|
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Caplyta | $388 | 3 payments
|
| E.R. Squibb & Sons L.L.C. | Cobenfy | $242 | 4 payments
|
| Axsome Therapeutics | Auvelity | $179 | 4 payments
|
| Vanda Pharmaceuticals | Fanapt | $132 | 2 payments
|
| Otsuka America Pharmaceutical | Rexulti | $113 | 4 payments
|
See all 27 published payments
| Otsuka America Pharmaceutical | Meals · 2025-12-01 | Rexulti | $30 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-11-24 | Cobenfy | $28 |
| Axsome Therapeutics | Meals · 2025-11-21 | Auvelity | $1 |
| Axsome Therapeutics | Meals · 2025-11-21 | Auvelity | $32 |
| Teva Pharmaceuticals USA | Meals · 2025-11-18 | Austedo Xr | $31 |
| Otsuka America Pharmaceutical | Meals · 2025-11-13 | Rexulti | $32 |
| Vanda Pharmaceuticals | Meals · 2025-11-05 | Hetlioz | $32 |
| Otsuka America Pharmaceutical | Meals · 2025-10-28 | Rexulti | $25 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-10-28 | Caplyta | $142 |
| Vanda Pharmaceuticals | Meals · 2025-10-27 | Fanapt | $100 |
| Teva Pharmaceuticals USA | Meals · 2025-10-16 | Austedo Xr | $125 |
| Teva Pharmaceuticals USA | Meals · 2025-10-15 | Austedo Xr | $21 |
| Janssen Pharmaceuticals | Meals · 2025-10-08 | Spravato | $26 |
| Axsome Therapeutics | Meals · 2025-10-08 | Auvelity | $118 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-09-26 | Cobenfy | $41 |
| Otsuka America Pharmaceutical | Meals · 2025-09-23 | Rexulti | $26 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-08-05 | Caplyta | $120 |
| Teva Pharmaceuticals USA | Meals · 2025-07-30 | Uzedy | $128 |
| Janssen Pharmaceuticals | Meals · 2025-07-09 | Spravato | $15 |
| Axsome Therapeutics | Meals · 2025-06-25 | Auvelity | $28 |
| GlaxoSmithKline | Meals · 2025-06-24 | Nucala | $29 |
| Teva Pharmaceuticals USA | Meals · 2025-05-16 | Austedo Xr | $25 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-04-25 | Cobenfy | $9 |
| Teva Pharmaceuticals USA | Education · 2025-04-22 | None | $111 |
| Janssen Pharmaceuticals | Meals · 2025-04-19 | Spravato | $41 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-03-05 | Cobenfy | $164 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-02-06 | Caplyta | $125 |
See earlier years (2024, 2023, 2022, 2021)
2024: $1,262
| Teva Pharmaceuticals USA | Austedo Xr | $466 | 10 payments
|
| Janssen Pharmaceuticals | Spravato | $393 | 4 payments
|
| Abbvie | Vraylar | $124 | 5 payments
|
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Caplyta | $124 | 1 payment
|
| Vanda Pharmaceuticals | Fanapt | $108 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Cobenfy | $27 | 1 payment
|
| Alkermes | Aristada | $19 | 1 payment
|
2023: $706
| Teva Pharmaceuticals USA | Austedo Xr | $269 | 3 payments
|
| Iti | Caplyta | $227 | 2 payments
|
| Abbvie | Vraylar | $105 | 5 payments
|
| Janssen Pharmaceuticals | Spravato | $53 | 1 payment
|
| Alkermes | Aristada | $27 | 1 payment
|
| Neuronetics | Neurostar Tms Therapy System | $25 | 1 payment
|
2022: $248
| Neurocrine Biosciences | Ingrezza | $127 | 1 payment
|
| Iti | Caplyta | $121 | 2 payments
|
2021: $47
| Iti | Caplyta | $47 | 1 payment
|
Professional record
- NPI
- 1447638234
- Licence
- CA 95001795
- Group
- Foveo Healthcare A Professional Medical Corporation · All for Health Health for All Inc
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LP0808X (363LP0808X); Nurse practitioner (363L00000X)
- Mailing address
- 500 E Olive Ave Ste 310, Burbank, CA, 91501
- NPI first listed
- 2015-05-12
- NPI last updated
- 2024-12-30
- NPI record certified
- 2024-12-22
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 141 S Cedar St, Glendale, CA, 91205